FDA Inspection 806108 — Biomat USA, Inc

Biomat USA, Inc — FEI 2377779

The FDA completed an inspection of Biomat USA, Inc on November 1, 2012 in Bellflower, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 1, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bellflower, CA (United States)